Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Amplia uncovers new clue in pancreatic cancer drug trial

Amplia Therapeutics has advanced its cancer drug narmafotinib across four trials, with data suggesting it may work independently of common tumour-causing KRAS gene mutations.

Amplia uncovers new clue in pancreatic cancer drug trial

We haven't written up this one. The Age has the full story — the link below goes straight to it.

Read the original at theage.com.au →

More in Health & Medicine

More from Thursday 22 October →